Strongbridge Biopharma Plc (SBBP)

Trade SBBP now with
7/7/2020 7:42:12 AM Strongbridge Biopharma Names John Johnson To Become CEO
7/1/2020 7:40:28 AM Strongbridge: Last Participant Completed Last Study Visit In Randomized Withdrawal Phase Of LOGICS Study For RECORLEV
5/11/2020 7:45:57 AM Strongbridge Biopharma Completes Enrollment Of Phase 3 LOGICS Study For RECORLEV
10/17/2019 7:39:10 AM Strongbridge Biopharma Presents KEVEYIS Primary Periodic Paralysis Data At 2019 AANEM Annual Meeting
9/19/2019 7:35:05 AM Strongbridge Biopharma Publishes Positive Pivotal Phase 3 SONICS Study Of RECORLEV In Lancet Diabetes & Endocrinology
7/19/2019 7:37:55 AM Strongbridge Biopharma Announces Inducement Equity Awards To Eight Individuals
4/15/2019 7:34:58 AM Strongbridge To Present New Data From Phase 3 SONICS Study Of RECORLEV
3/11/2019 7:43:42 AM Strongbridge Reports Top-Line Results From Extended Evaluation Phase Of Pivotal Phase 3 SONICS Study Of RECORLEV
2/26/2019 7:39:13 AM Strongbridge Biopharma Q4 EPS $1.73 Vs Loss $0.47 Last Year
11/20/2018 7:35:21 AM Strongbridge Announces Presentation Of New Data Comparing The In Vitro Effects Of Levoketoconazole
10/31/2018 8:48:35 AM Strongbridge Biopharma Q3 Basic Net Loss Attributable To Ordinary Shareholders $20.6 Mln Or $0.44 Per Share
10/22/2018 7:40:46 AM Strongbridge Biopharma Presents Detailed Initial Results From Pivotal Phase 3 SONICS Study Of RECORLEV
8/8/2018 6:39:08 AM Strongbridge Biopharma Q2 Loss Per Share 40.06 Vs Loss $0.86 Last Year
8/8/2018 6:36:39 AM Strongbridge Biopharma Announces Positive Top-Line Results From Pivotal Phase 3 SONICS Study Of RECORLEV